VERU
Veru Inc
Halal Rating :
Last Price
$0.98
Last updated:
Market Cap
-
7D Change
28.58%
1 Year Change
147.47%
Company Overview
Industries
Exchange
Next Earnings Date
Veru Inc. is a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral and ARDS-related diseases. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in 2017. They are also involved in developing treatments for breast and prostate cancers.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $6.66m | $15.03m | - | $169867.0 | 0.00% | 1.13% |
| June 30, 2024 | $3.95m | $15.02m | - | $127336.0 | 0.00% | 0.85% |
| March 31, 2024 | $4.14m | $14.17m | - | $145310.0 | 0.00% | 1.03% |
Company Impact
Help us evaluate Veru Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.